Market Cap (In KRW)
238.79 Billion
Revenue (In KRW)
151.07 Billion
Net Income (In KRW)
3.58 Billion
Avg. Volume
29.94 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 11170.0-18650.0
- PE
- -
- EPS
- -
- Beta Value
- 0.915
- ISIN
- KR7102460003
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ms. Soon-Ock Jung
- Employee Count
- -
- Website
- https://reyonpharm.co.kr
- Ipo Date
- 2010-06-10
- Details
- REYON Pharmaceutical Co., Ltd. manufactures and sells finished medicines and APIs in South Korea and internationally. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; migraine drugs; miscellaneous cardiovascular system drugs; neuromuscular disorder related drugs; nootropics and neurotonics; NSAIDs; respiratory stimulants; skeletal muscle relaxants; and vasodilators. REYON Pharmaceutical Co., Ltd. was founded in 1955 and is headquartered in Seoul, South Korea.
More Stocks
-
001020PaperCorea Inc.
001020
-
ZEVY
-
OPTIEMUSOptiemus Infracom Limited
OPTIEMUS
-
TOM2TomTom N.V.
TOM2
-
ROQ
-
600111
-
RPPINFRAR.P.P. Infra Projects Limited
RPPINFRA
-
VIBEFVibe Growth Corporation
VIBEF